Pune, India, November 30, 2021 (GLOBE NEWSWIRE) – The global dermal filler market is expected to reach 6.28 billion U.S. dollars by 2028, and at the same time, the compound annual growth rate from 2021 to 2028 will reach 10.8%. People are impressed.In its title “dermal filler market 2021-2028″, “Fortune Business Insights” mentioned that the market size in 2020 will be 2.84 billion U.S. dollars.
The increasing investment in the R&D department of the medical cosmetics industry is expected to drive the growth of the dermal filler market.In addition, the upward trend and prevalence of filler therapy have increased dramatically over the years.For example, in a 2019 report by the International Society of Aesthetic Plastic Surgery (ISAPS), an estimated 4,315,859 surgeries involving hyaluronic acid fillers were performed globally in 2019.This figure is an increase of 15.7% over 2018.The increase in such procedures is expected to drive market growth.
Request a sample copy of the research report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermal-fillers-market-100939
The impact of COVID-19 is obvious in the healthcare sector because it is at the center of this unprecedented global pandemic challenge.The medical cosmetics industry is particularly affected because it is a non-essential and optional service.As a result of the blockade, the industry has witnessed supply chain disruptions due to import and export restrictions, flight closures, reduced production, and interrupted supply channels.For example, the revenue of JUVEDERM Collection of ALLERGAN (AbbVie, Inc.), a strong player in the global market, fell 42.3% compared to fiscal year 2019 (FY).However, the market is expected to prosper again during the forecast period.
According to materials, the market is divided into hyaluronic acid, calcium hydroxyapatite, poly-l-lactic acid, PMMA (poly(methyl methacrylate)), fatty fillers, etc.According to the product, the market is divided into biodegradable and non-biodegradable.According to its application, the market is divided into scar treatment, wrinkle correction treatment, lip augmentation, and fullness restoration.For end users, it is divided into specialist and dermatological clinics, hospitals and clinics, etc.
According to the trend, the market share of hyaluronic acid segment is the highest in 2020, at 77.1%.This is due to the increased demand for hyaluronic acid products due to their safety and relatively long life.In addition, many companies provide hyaluronic acid products in countries with stable and high-growth economies such as Europe.In this region, AbbVie, Inc. is expected to promote the growth of this segment during the forecast period.
Quick Buy-Dermal Filler Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100939
Due to the high disposable income of people in this region, North America is expected to maintain its leading position and occupy the highest position in the market during the forecast period.In addition, it is expected that strict rules and regulations related to new products will promote the development of the regional market.For example, according to data from the American Society of Plastic Surgeons (ASPS), in 2019, approximately 16.3 million cosmetic minimally invasive procedures were performed in the United States, and the market size in 2020 was US$1.22 billion.
The Asia-Pacific region is expected to show a considerable market share of hosting services.This is due to the increasing awareness of people about their appearance in the area.For example, in July 2020, South Korea’s LG Chem announced that they had launched a clinical trial of a high-quality dermal filler called YVOIRE Y-Solution in China.Therefore, its launch is expected to boost the regional market during the forecast period.
have any doubt?Consult our experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dermal-fillers-market-100939
Major companies strive to maintain their position by focusing on the release of new products, thereby consolidating the market.For example, in August 2020, Revance Therapeutics, Inc. launched the RHA Dermal Filler Line.It is the first and only dermal filler approved by the FDA to correct dynamic facial wrinkles and wrinkles in the United States.This aggressive strategy is expected to drive the market in the next few years.
Get your customized research report: https://www.fortunebusinessinsights.com/enquiry/customization/dermal-fillers-market-100939
Fortune Business Insights™ provides professional enterprise analysis and accurate data to help organizations of all sizes make timely decisions.We tailor innovative solutions for our customers to help them cope with the unique challenges facing their business.Our goal is to provide our customers with comprehensive market intelligence and a detailed overview of the markets in which they operate.
Our report contains a unique combination of tangible insights and qualitative analysis to help companies achieve sustainable growth.Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market research, interspersed with relevant data.
At Fortune Business Insights™, our goal is to highlight the most profitable growth opportunities for our customers.Therefore, we provide suggestions to enable them to more easily respond to changes in technology and the market.Our consulting services are designed to help organizations identify hidden opportunities and understand current competitive challenges.
Fortune Business Insight™ Pvt.Ltd. 308, Supreme Leadership, Survey No. 36, Baner, Pune-Bangalore Highway, Pune-411045, Maharashtra, India.
Phone: United States: +1 424 253 0390 UK: +44 2071 939123 APAC: +91 744 740 1245 Email: sales@fortunebusinessinsights.comFortune Business Insights™ LinkedIn | Twitter | Blog
Post time: Dec-24-2021